Business Wire- ALung Technologies, Inc., the leading provider of low-flow extracorporeal carbon dioxide removal (ECCO2R) technologies for treating patients with acute respiratory failure, announced today the closing of a $36 million Series C financing, including existing convertible notes.
ALung Technologies Closes $36 Million Financing
April 11, 2017
You Might Also Like…
more from the blog
